Anti-HIF-1 alpha antibody - C-terminal (ab228649)
Key features and details
- Rabbit polyclonal to HIF-1 alpha - C-terminal
- Suitable for: WB, IP, IHC-P, ChIP, ICC/IF
- Reacts with: Mouse, Human
- Isotype: IgG
Overview
-
Product name
Anti-HIF-1 alpha antibody - C-terminal
See all HIF-1 alpha primary antibodies -
Description
Rabbit polyclonal to HIF-1 alpha - C-terminal -
Host species
Rabbit -
Tested Applications & Species
See all applications and species dataApplication Species ChIP HumanICC/IF HumanIHC-P MouseHumanIP HumanWB MouseHuman -
Immunogen
Recombinant fragment within Human HIF-1 alpha (C terminal). The exact sequence is proprietary.
Database link: Q16665 -
Positive control
- ICC/IF: CoCl2 treated HeLa and NIH/3T3 cells. WB: O2 treated HepG2 and MCF7 whole cell extracts; CoCL2 treated HepG2, NIH/3T3 and HeLa whole cell extracts.; HIF-1 alpha transfected HEK-293T whole cell extract. IHC-P: Human kidney cancer tissue. ChIP: HepG2 chromatin extract. IP: CoCl2 treated HepG2 whole cell extract.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.00
Preservative: 0.025% Proclin 300
Constituents: 78% PBS, 1% BSA, 20% Glycerol (glycerin, glycerine) -
Concentration information loading...
-
Purity
Immunogen affinity purified -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Images
-
All lanes : Anti-HIF-1 alpha antibody - C-terminal (ab228649) at 1/1000 dilution
Lane 1 : Untreated HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell extract
Lane 2 : HeLa (human epithelial cell line from cervix adenocarcinoma) treated with 500 µM CoCl2 for 24 hours, whole cell extract
Lysates/proteins at 30 µg per lane.
Predicted band size: 93 kDa7.5% SDS-PAGE gel.
-
4% paraformaldehyde-fixed HeLa (human epithelial cell line from cervix adenocarcinoma) cells stained for HIF-1 alpha (green) using ab228649 at 1/500 dilution in ICC/IF.
Counterstain: Phalloidin, a cytoskeleton marker, at 1/100 dilution (red).
-
All lanes : Anti-HIF-1 alpha antibody - C-terminal (ab228649) at 1/500 dilution
Lane 1 : NIH/3T3 (mouse embryo fibroblast cell line) whole cell extract
Lane 2 : NIH/3T3 (mouse embryo fibroblast cell line) treated with 500 µM CoCl2 for 24 hours, whole cell extract
Lysates/proteins at 30 µg per lane.
Secondary
All lanes : HRP-conjugated anti-rabbit IgG
Predicted band size: 93 kDa7.5% SDS-PAGE gel.
-
All lanes : Anti-HIF-1 alpha antibody - C-terminal (ab228649) at 1/5000 dilution
Lane 1 : Non-transfected HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell extract
Lane 2 : HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) transfected with Flag-tagged HIF-1 alpha, whole cell extract
Lysates/proteins at 30 µg per lane.
Secondary
All lanes : HRP-conjugated anti-rabbit IgG
Predicted band size: 93 kDa7.5% SDS-PAGE gel.
-
ChIP was performed with HepG2 (human liver hepatocellular carcinoma cell line) chromatin extract and 5 μg of either normal rabbit IgG or ab228649. The precipitated DNA was detected by PCR with primer set targeting to VEGF promoter.
-
All lanes : Anti-HIF-1 alpha antibody - C-terminal (ab228649) at 1/1000 dilution
Lane 1 : Untreated HepG2 (human liver hepatocellular carcinoma cell line) whole cell extract
Lane 2 : HepG2 (human liver hepatocellular carcinoma cell line) treated with 1% O2 for 24 hours, whole cell extract
Lysates/proteins at 30 µg per lane.
Secondary
All lanes : HRP-conjugated anti-rabbit IgG
Predicted band size: 93 kDa7.5% SDS-PAGE gel.
-
HIF-1 alpha was immunoprecipitated from HepG2 (human liver hepatocellular carcinoma cell line) treated with 500 μM CoCl2 for 24 hours, whole cell extract using 5 µg of ab228649. Western blot was performed from the immunoprecipitate using ab228649.
Lane 1: Control IgG IP in HepG2 treated with 500 μM CoCl2 for 24 hours, whole cell extracts.
Lane 2: ab228649 IP in HepG2 treated with 500 μM CoCl2 for 24 hours, whole cell extracts. -
4% paraformaldehyde-fixed, treated and mock-treated NIH/3T3 (mouse embryo fibroblast cell line) cells stained for HIF-1 alpha (green) using ab228649 at 1/200 dilution in ICC/IF.
Nuclear counterstain: Hoechst 33342 (blue).
-
All lanes : Anti-HIF-1 alpha antibody - C-terminal (ab228649) at 1/5000 dilution
Lane 1 : Untreated HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate
Lane 2 : HepG2 (human liver hepatocellular carcinoma cell line) treated with 200 µM CoCl2 for 24 hours, whole cell lysate
Lane 3 : HepG2 (human liver hepatocellular carcinoma cell line) treated with 500 µM CoCl2 for 24 hours, whole cell lysate
Lysates/proteins at 30 µg per lane.
Secondary
All lanes : HRP-conjugated anti-rabbit IgG
Predicted band size: 93 kDa7.5% SDS-PAGE gel.
-
Paraffin-embedded human kidney cancer tissue stained for HIF-1 alpha using ab228649 at 1/500 dilution in immunohistochemical analysis.
-
All lanes : Anti-HIF-1 alpha antibody - C-terminal (ab228649) at 1/1000 dilution
Lane 1 : Non-transfected, untreated MCF7 (human breast adenocarcinoma cell line) whole cell extract
Lanes 2-3 & 5 : HIF-1 alpha shRNA-transfected, untreated MCF7 (human breast adenocarcinoma cell line) whole cell extract
Lane 4 : HIF-1 alpha shRNA-transfected, untreated MCF7 (human breast adenocarcinoma cell line) whole cell extracts
Lane 6 : Non-transfected MCF7 (human breast adenocarcinoma cell line) treated with 1% O2, whole cell extract
Lanes 7-10 : HIF-1 alpha shRNA-transfected MCF7 (human breast adenocarcinoma cell line) treated with 1% O2, whole cell extract
Lysates/proteins at 30 µg per lane.
Secondary
All lanes : HRP-conjugated anti-rabbit IgG
Predicted band size: 93 kDa7.5% SDS-PAGE gel.
-
4% paraformaldehyde-fixed untreated (left panel) and 500 μM CoCl2 treated (right panel) HeLa (human epithelial cell line from cervix adenocarcinoma) cells stained for HIF-1 alpha (green) using ab228649 at 1/500 dilution in ICC/IF.
Nuclear counterstain: Phalloidin, a cytoskeleton marker, at 1/100 dilution (red).